cabergoline

chemical compound
Class type of: ergoline alkaloid Q423308

Facts

14 properties
Instance of
type of chemical entity
Has use
medication
Canonical SMILES
CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C
Chemical formula
C₂₆H₃₇N₅O₂
Defined daily dose
3 mg, 0.5 mg
Isomeric SMILES
CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
Mass
451.294725 Da
Medical condition treated
Parkinson's disease, hyperprolactinemia, benign neoplasm of pituitary gland, prolactin producing pituitary tumor, prolactinoma
Pregnancy category
US pregnancy category B
World Health Organisation international non-proprietary name
cabergoline
🏷️ Also known as
en Cabergolinum en Caberlin® en 1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea en 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea en 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea en 1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea en 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea en 1-Ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea en (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide en (8beta)-N-[3-(dimethylamino)Propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide en (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide en (8R)-6-Allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide en Cabaser® en Cabergolina en cabergoline en Cabergoline ar كابرجولين de Cabergolin es Dostinex fa کابرگولین
🔖 Identifiers · 36
OpenAlex ID
C2779832395
ATC code
N04BC06, G02CB03
CAS Registry Number
81409-90-7
ChEBI ID
3286
ChEMBL ID
CHEMBL1201087
ChemSpider ID
49452
DSSTOX compound identifier
DTXCID502719
DSSTox substance ID
DTXSID6022719
DeCS ID
57653
DrugBank ID
DB00248
DrugCentral ID
460
EC number
627-031-8
Show all 36 identifiers +24
ECHA Substance Infocard ID
100.155.380
Electronic Essential Medicines List medicine ID
593
Freebase ID
/m/051b_1
Guide to Pharmacology Ligand ID
37
Human Metabolome Database ID
HMDB0014393
KEGG ID
C08187, D00987
MeSH descriptor ID
D000077465
MedlinePlus drug identifier
a612020
Microsoft Academic ID (discontinued)
2779832395
NDF-RT ID
N0000148483
Probes And Drugs ID
PD010146
PubChem CID
54746
Quora topic ID
Cabergoline
Reaxys registry number
6020775
RxNorm CUI
47579
Römpp online ID
RD-03-00015
SureChEMBL ID
42292
UMLS CUI
C0107994
UniChem compound ID
610539
WikiProjectMed ID
Cabergoline

Report an error or request removal Lineage (PROV-JSON)

Press Enter · cited answer in seconds

Summary

cabergoline is a type of chemical entity[1].

Key Facts

  • Physically interacts with: 5-hydroxytryptamine receptor 1A[2], 5-hydroxytryptamine receptor 1B[3], 5-hydroxytryptamine receptor 1D[4], 5-hydroxytryptamine receptor 2A[5], 5-hydroxytryptamine receptor 2B[6], 5-hydroxytryptamine receptor 2C[7], Adrenoceptor alpha 1A[8], Adrenoceptor alpha 2A[9], Adrenoceptor alpha 2B[10], Adrenoceptor alpha 2C[11], Dopamine receptor D1[12], Dopamine receptor D2[13], Dopamine receptor D3[14], Dopamine receptor D4[15]
  • Canonical SMILES: CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C[16]
  • Chemical formula: C₂₆H₃₇N₅O₂[17]
  • Subclass of: ergoline alkaloid[18]
  • Has use: medication[19]
  • Significant drug interaction: levomepromazine[20], zuclopenthixol[21], (Z)-flupentixol[22], (RS)-sulpiride[23], droperidol[24], fluphenazine[25], haloperidol[26], chlorpromazine[27]
  • Isomeric SMILES: CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2C@@HN(C1)CC=CC@@HN(C1)CC=C">[28]
  • Mass: 451.294725 dalton[29]
  • Medical condition treated: Parkinson's disease[30], hyperprolactinemia[31], benign neoplasm of pituitary gland[32], prolactin producing pituitary tumor[33], prolactinoma[34]
  • World Health Organisation international non-proprietary name: cabergoline[35]
  • Subject has role: dopamine agonist[36], antiparkinson[37], antineoplastic[38]
  • Pregnancy category: US pregnancy category B[39]
  • Defined daily dose: 3 milligram[40], 0.5 milligram[41]

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  2. [3] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  3. [4] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  4. [5] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  5. [6] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  6. [7] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  7. [8] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  8. [9] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  9. [10] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  10. [11] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  11. [12] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  12. [13] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  13. [14] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  14. [15] ↑ . IUPHAR/BPS Guide to PHARMACOLOGY. Retrieved . wikidata.org.
  15. [16] ↑ . PubChem. Retrieved . wikidata.org.
  16. [17] ↑ . PubChem. Retrieved . wikidata.org.
  17. [18] ↑ . NDF-RT. Retrieved . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  20. [21] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  21. [22] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  22. [23] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  23. [24] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  24. [25] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  25. [26] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  26. [27] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  27. [28] ↑ . PubChem. Retrieved . wikidata.org.
  28. [29] ↑ . PubChem. Retrieved . wikidata.org.
  29. [30] ↑ . NDF-RT. Retrieved . wikidata.org.
  30. [31] ↑ . NDF-RT. Retrieved . wikidata.org.
  31. [32] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  32. [33] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  33. [34] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  34. [35] ↑ . ChEBI. Retrieved . wikidata.org.
  35. [36] ↑ . NDF-RT. Retrieved . wikidata.org.
  36. [37] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  37. [38] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  38. [39] ↑ . wikidata.org.
  39. [40] ↑ . whocc.no. whocc.no. Provenance: wikidata.org.
  40. [41] ↑ . whocc.no. whocc.no. Provenance: wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). cabergoline. Retrieved November 17, 2026, from https://4ort.xyz/entity/cabergoline
MLA “cabergoline.” 4ort.xyz Knowledge Graph, 4ort.xyz, 17 Nov. 2026, https://4ort.xyz/entity/cabergoline.
BibTeX @misc{4ortxyz_cabergoline_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{cabergoline}}, year = {2026}, url = {https://4ort.xyz/entity/cabergoline}, note = {Accessed: 2026-11-17}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): cabergoline — https://4ort.xyz/entity/cabergoline (retrieved 2026-11-17)

Canonical URL: https://4ort.xyz/entity/cabergoline · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 21w ago · Nabbegat · 2026-06-19 view diff on Wikidata ↗
    Defined daily dose → 3 milligram, 0.5 milligram
    Instance of → type of chemical entity
    Has use → medication
    Medical condition treated → Parkinson's disease, hyperprolactinemia, benign neoplasm of pituitary gland +1
    + 6 other properties edited (see Wikidata diff for full list)
    "Changed [tr] labels, descriptions or aliases: QuickStatements 3.0 batch #37300"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.